agilon health, inc.
AGL
$1.20
-$0.01-0.83%
NYSE
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -9.01% | 0.70% | |||
Total Other Revenue | 1.38% | -10.46% | |||
Total Revenue | -8.99% | 0.68% | |||
Cost of Revenue | -2.34% | -5.04% | |||
Gross Profit | -203.36% | 232.59% | |||
SG&A Expenses | -14.17% | 9.21% | |||
Depreciation & Amortization | 6.44% | 5.88% | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -2.80% | -4.47% | |||
Operating Income | -436.98% | 79.38% | |||
Income Before Tax | -6,064.78% | 98.38% | |||
Income Tax Expenses | -68.37% | -88.84% | |||
Earnings from Continuing Operations | -5,428.07% | 98.23% | |||
Earnings from Discontinued Operations | -- | 2,087.50% | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -961.71% | 111.45% | |||
EBIT | -436.98% | 79.38% | |||
EBITDA | -638.25% | 85.02% | |||
EPS Basic | -960.75% | 111.41% | |||
Normalized Basic EPS | -8,644.44% | 98.83% | |||
EPS Diluted | -960.75% | 111.35% | |||
Normalized Diluted EPS | -8,644.44% | 98.83% | |||
Average Basic Shares Outstanding | 0.22% | 0.22% | |||
Average Diluted Shares Outstanding | 0.22% | 0.22% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |